Epigenetic modifications, such as DNA methylation and post-translation modifications of histones, have been shown to play an important role in chromatin structure, promoter activity, and cellular reprogramming. Large protein complexes, such as Polycomb and trithorax, often harbor multiple activities which affect histone tail modification. Nevertheless, the mechanisms underlying the deposition of these marks, their propagation during cell replication, and the alteration on their distribution during transformation still require further study. Here we review recent data on those processes in both normal and cancer cells, and we propose that the unscheduled expression of oncogenic transcription factors causes reprogramming of normal cells into cancer stem cells.

Download full-text PDF

Source
http://dx.doi.org/10.1002/bies.201000016DOI Listing

Publication Analysis

Top Keywords

setting resetting
4
resetting epigenetic
4
epigenetic marks
4
marks malignant
4
malignant transformation
4
transformation development
4
development epigenetic
4
epigenetic modifications
4
modifications dna
4
dna methylation
4

Similar Publications

Background: Substance use disorders (SUDs) result in individual and societal burden. However, most individuals with SUD receive no treatment. Implementing SUD interventions in primary care could address this population's treatment needs.

View Article and Find Full Text PDF

Non-conventional deep brain stimulation in a network model of movement disorders.

Biomed Phys Eng Express

December 2024

Department of Mathematics and Statistics, University of Exeter, United Kingdom.

Conventional deep brain stimulation (DBS) for movement disorders is a well-established clinical treatment. Over the last few decades, over 200,000 people have been treated by DBS worldwide for several neurological conditions, including Parkinson's disease and Essential Tremor. DBS involves implanting electrodes into disorder-specific targets in the brain and applying an electric current.

View Article and Find Full Text PDF

Biliary sphincterotomy resets pancreaticobiliary pain refractory to intrasphincteric Botox injections in functional biliary pain.

Indian J Gastroenterol

December 2024

Department of Gastroenterology, The Royal Wolverhampton NHS Trust, New Cross Hospital, Wednesfield Road, Wolverhampton, WV10 0QP, UK.

Background: The management of Type III sphincter of Oddi dysfunction or functional biliary pain (FBP) is challenging. A strategy of intermittent intrasphincteric botulinum toxin (Botox) injections into the sphincter of Oddi can alleviate pancreaticobiliary pain. In patients who lose response to intermittent Botox injections, endoscopic biliary sphincterotomy (ES) could potentially reset pain facilitating ongoing management of symptoms.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on how families of children with neurodisabilities in England experienced changes in health, education, and social care services during the COVID-19 pandemic.
  • It involved qualitative interviews with 48 parent carers and 9 young people, revealing significant disruptions in communication and access to services.
  • Four key themes emerged: poor communication of changes, varying access to services, detrimental impacts on families, and recommendations for future emergencies.
View Article and Find Full Text PDF

T cell immune tolerance is established in part through the activity of the Auto-immune Regulator (AIRE) transcription factor in the medullary Thymic Epithelial Cells (mTEC) of the thymus. AIRE induces expression of SELF peripheral tissue-specific antigens for presentation to naïve T cells to promote activation/deletion of potentially autoreactive T cells. We show, for the first time to our knowledge, that tumors mimic the role of AIRE in mTEC to evade immune rejection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!